A Pivotal Study of Safety and Effectiveness of NanoKnife IRE for Stage 3 Pancreatic Cancer
Trial details
- Registry ID
- NCT03899636
- Phase
- Phase 3
Drug identity has not yet been verified against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Pivotal Study of Safety and Effectiveness of NanoKnife IRE for Stage 3 Pancreatic CancerNCT03899636 | ANGO | Phase 3 | Active not recruiting | 2025-04Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |